Profit with us in the 2009 bear market
Research Report
Hotstocked.com has a complete research report available for BCRX stock. Download BCRX report.
Research Report
Get the full report for FREE
Date:Aug 12, 2009
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download BCRX report
  
Example preview: Research report for Biocryst Pharm, Inc (BCRX) Research report for Biocryst Pharm, Inc (BCRX) Research report for Biocryst Pharm, Inc (BCRX) Research report for Biocryst Pharm, Inc (BCRX)
   

Cash Flow for Biocryst Pharm, Inc (BCRX)

Markets Quote Depth/LII Options Charts News Company Financials Insiders Filings Analyst Earnings Historical
Symbol:  | Recent Quotes powered by
  quotemedia.com
Cash Flow for Biocryst Pharmaceuticals Inc.  (BCRX) 
$ 9.55   -0.85 (-8.17%) Volume: 6.75 m 4:00 PM EST Nov 20, 2009
After Hours:  $ 9.53   -0.02 (-0.21%) Volume: 43.0 k 7:54 PM EST Nov 20, 2009
Statement: View:
Cash Flow in Thousands of Dollars
12/2008 12/2007 12/2006 12/2005 12/2004
Net Income (24,732) (29,056) (43,618) (26,099) (21,104)
Depreciation & Amortization 1,626 1,370 802 854 966
Deferred Income Taxes - - - - -
Operating Losses - - (25) 180 521
Extraordinary Losses - - - - -
Decrease in Receivables 27,145 (34,572) 25,444 (30,000) -
Decrease in Inventories - - - - -
Decrease in Other Current Assets - - - - -
Increase in Payables (8,957) 15,424 (2,926) 6,843 1,330
Increase in Other Current Liabilities - 15,057 453 25,006 156
Decrease in Other Working Capital (21,629) (809) 4,223 - -
Other Non-Cash Items 5,861 5,691 3,353 - -
Net Cash from Continuing Operations (20,874) (24,998) (15,211) (23,346) (18,151)
Net Cash from Discontinued Operations - - - - -
Cash from Operating Activities (20,874) (24,998) (15,211) (23,346) (18,151)
Sale of Property, Plant, Equipment - - - - -
Sale of Short Term Investments 137,066 51,218 31,916 18,729 16,399
Purchase of Property, Plant, Equipment (1,212) - (1,535) (497) (276)
Acquisitions - (3,344) - - -
Purchase of Short Term Investments (124,460) (62,907) (42,871) (29,695) (18,879)
Other Investment Changes, Net - - - (51) (80)
Cash from Investing Activities 11,394 (15,033) (12,489) (11,514) (2,837)
Issuance of Debt - - - - -
Issuance of Capital Stock 667 66,769 2,961 55,179 21,479
Repayment of Debt - - - - -
Repurchase of Capital Stock - - - - -
Payment of Cash Dividends - - - - -
Other Financing Charges, Net - - - - -
Cash from Financing Activities 667 66,769 2,961 55,179 21,479
Effect of Exchange Rate Changes - - - - -
Net Change in Cash (8,813) 26,738 (24,739) 20,318 490
Cash at Beginning of Year 31,155 4,418 29,157 8,838 8,348
Cash at End of Period 22,342 31,155 4,418 29,157 8,838

Copyright © QuoteMedia.   Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).   RT   Realtime,  DL+   Realtime BATS,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia, financials by Morningstar.  Terms of Use. 
   
 
Home > Companies > Biocryst Pharm, Inc